100 related articles for article (PubMed ID: 15665522)
1. Adrenomedullin impairs the profibrotic effects of transforming growth factor-beta1 through recruiting Smad6 protein in human renal tubular cells.
Huang H; Ma C; Yang M; Tang C; Wang H
Cell Physiol Biochem; 2005; 15(1-4):117-24. PubMed ID: 15665522
[TBL] [Abstract][Full Text] [Related]
2. [The antagonistic effects of adrenomedullin on biological events governed by transforming growth factor beta in HK-2 cell line].
Ma C; Wang H
Zhonghua Yi Xue Za Zhi; 2001 Apr; 81(8):476-9. PubMed ID: 11798922
[TBL] [Abstract][Full Text] [Related]
3. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway.
Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F
Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899
[TBL] [Abstract][Full Text] [Related]
4. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
5. Increased glomerular and tubular expression of transforming growth factor-beta1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse.
Hong SW; Isono M; Chen S; Iglesias-De La Cruz MC; Han DC; Ziyadeh FN
Am J Pathol; 2001 May; 158(5):1653-63. PubMed ID: 11337363
[TBL] [Abstract][Full Text] [Related]
6. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
Yang J; Dai C; Liu Y
J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
[TBL] [Abstract][Full Text] [Related]
7. Adrenomedullin regulates expressions of transforming growth factor-beta1 and beta1-induced matrix metalloproteinase-2 in hepatic stellate cells.
Wang Y; Zhang JS; Qian J; Huang GC; Chen Q
Int J Exp Pathol; 2006 Jun; 87(3):177-84. PubMed ID: 16709226
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
Hayashida T; Decaestecker M; Schnaper HW
FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
[TBL] [Abstract][Full Text] [Related]
9. Resistance to transforming growth factor-beta occurs in the presence of normal Smad activation.
Berger DH; Feng XH; Yao J; Saha D; Beauchamp RD; Lin X
Surgery; 2002 Aug; 132(2):310-6. PubMed ID: 12219028
[TBL] [Abstract][Full Text] [Related]
10. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
[TBL] [Abstract][Full Text] [Related]
11. Differential induction of early response genes by adrenomedullin and transforming growth factor-beta1 in human lung cancer cells.
Kane S; Prentice MA; Mariano JM; Cuttitta F; Jakowlew SB
Anticancer Res; 2002; 22(3):1433-44. PubMed ID: 12168820
[TBL] [Abstract][Full Text] [Related]
12. Atrial natriuretic peptide attenuates high glucose-activated transforming growth factor-beta, Smad and collagen synthesis in renal proximal tubular cells.
Lo CS; Chen ZH; Hsieh TJ; Shin SJ
J Cell Biochem; 2008 Apr; 103(6):1999-2009. PubMed ID: 17960594
[TBL] [Abstract][Full Text] [Related]
13. Ectopic expression of Smad7 inhibits transforming growth factor-beta responses in vascular smooth muscle cells.
Kato S; Ueda S; Tamaki K; Fujii M; Miyazono K; ten Dijke P; Morimatsu M; Okuda S
Life Sci; 2001 Oct; 69(22):2641-52. PubMed ID: 11712667
[TBL] [Abstract][Full Text] [Related]
14. Smad signal and TGFbeta induced apoptosis in human lymphoma cells.
Sebestyén A; Barna G; Nagy K; Jánosi J; Paku S; Kohut E; Berczi L; Mihalik R; Kopper L
Cytokine; 2005 Jun; 30(5):228-35. PubMed ID: 15927846
[TBL] [Abstract][Full Text] [Related]
15. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3.
Guh JY; Chuang TD; Chen HC; Hung WC; Lai YH; Shin SJ; Chuang LY
Kidney Int; 2003 Dec; 64(6):2041-51. PubMed ID: 14633126
[TBL] [Abstract][Full Text] [Related]
16. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
Baldwin RL; Tran H; Karlan BY
Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor Beta1 induction of tissue inhibitor of metalloproteinases 3 in articular chondrocytes is mediated by reactive oxygen species.
Li WQ; Qureshi HY; Liacini A; Dehnade F; Zafarullah M
Free Radic Biol Med; 2004 Jul; 37(2):196-207. PubMed ID: 15203191
[TBL] [Abstract][Full Text] [Related]
18. Hepatocyte growth factor suppresses renal interstitial myofibroblast activation and intercepts Smad signal transduction.
Yang J; Dai C; Liu Y
Am J Pathol; 2003 Aug; 163(2):621-32. PubMed ID: 12875981
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
Kim HS; Luo L; Pflugfelder SC; Li DQ
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):840-8. PubMed ID: 15728539
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARA.
Zhao BM; Hoffmann FM
Mol Biol Cell; 2006 Sep; 17(9):3819-31. PubMed ID: 16775010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
